Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
2003918 citationsJ Cinátl, Gabriele Bauer et al.The Lancetprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Doerr Hw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doerr Hw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doerr Hw more than expected).
This network shows the impact of papers produced by Doerr Hw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doerr Hw. The network helps show where Doerr Hw may publish in the future.
Co-authorship network of co-authors of Doerr Hw
This figure shows the co-authorship network connecting the top 25 collaborators of Doerr Hw.
A scholar is included among the top collaborators of Doerr Hw based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Doerr Hw. Doerr Hw is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Cinátl, J, et al.. (2003). Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. The Lancet. 361(9374). 2045–2046.918 indexed citations breakdown →
3.
Činátl, Jindřich, Chandra Prakash, Holger F. Rabenau, & Doerr Hw. (2003). Treatment of SARS with human interferons. The Lancet. 362(9390). 1158–1159.4 indexed citations
4.
Hw, Doerr, et al.. (2001). [Study of vaccination for travel shows: serious gaps in polio, diphtheria and tetanus vaccination].. PubMed. 143(28-29). 29–31.4 indexed citations
5.
Hw, Doerr, et al.. (1997). Application of automated thermal disinfection instead of sterilisation procedures for treatment of rotating dental instruments: efficacy against viruses?. PubMed. 200(2-3). 197–215.1 indexed citations
Činátl, Jindřich, et al.. (1994). In vitro anti-human cytomegalovirus activity of liposome-encapsulated foscarnet.. PubMed. 3(1). 5–8.5 indexed citations
8.
Činátl, Jindřich, et al.. (1993). In vitro anti-human immunodeficiency virus activity of 2',3'-dideoxynucleosides and their effect on clonal growth of hemopoietic cells from human bone marrow.. PubMed. 43(5). 622–5.2 indexed citations
9.
Falkenbach, A., et al.. (1993). [Incidence of Lyme borreliosis in a rheumatologic patient sample. Study of 153 patients of an internal medicine-rheumatologic ambulatory clinic].. PubMed. 111(24). 377–9.1 indexed citations
10.
Sibrowski, Walter, et al.. (1990). [Cytomegalovirus diagnosis in blood donors and risk patients].. PubMed. 26. 37–9.6 indexed citations
11.
Hw, Doerr, et al.. (1988). [Molecular epidemiology of rotavirus infections at units of children's hospitals].. PubMed. 187(1). 75–86.1 indexed citations
12.
Hw, Doerr. (1986). [Possibilities in the virological laboratory diagnosis of CNS infections].. PubMed. 14(4). 131–4.2 indexed citations
13.
Dreikorn, K., et al.. (1985). Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG.. PubMed. 92. 15–21.8 indexed citations
14.
Gmelin, K., Lorenz Theilmann, Hans Will, et al.. (1985). Determination of HBV DNA by a simplified method of spot hybridization.. PubMed. 32(3). 117–20.7 indexed citations
15.
Hw, Doerr, Ralph P. Braun, & Gisela Enders. (1983). [Rubella infection in pregnancy. Methods of determining risk].. PubMed. 125(9). 181–4.1 indexed citations
16.
Gmelin, K., et al.. (1983). Non-A, non-B hepatitis in hemodialysis.. PubMed. 54. 483–6.3 indexed citations
17.
Gmelin, K., et al.. (1983). Follow-up of needlesticks in medical staff.. PubMed. 54. 357–62.2 indexed citations
18.
Gmelin, K., et al.. (1983). Hepatitis markers in a psychiatric institution.. PubMed. 54. 545–8.4 indexed citations
19.
Gmelin, K., et al.. (1982). Hepatitis A and B markers and presumable non-A, non-B hepatitis in a psychiatric institution.. PubMed. 176(1). 15–27.2 indexed citations
20.
Hw, Doerr, Herbert Schmitz, & Petersen Ee. (1974). [Formation of antibody to nucleocapsid and envelope of Herpes simplex virus hominis].. PubMed. 227(1-4). 348–54.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.